---
schema_version: "secwatch.filing_event.v1"
accession: "0001528287-23-000040"
form_type: "8-K"
ticker: "NPCE"
cik: "0001528287"
company_name: "NeuroPace Inc"
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T19:51:39.790988+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# NeuroPace Q3 revenue $16.4M (+47% YoY), raises FY2023 guidance to $62.5-$63.5M

## Summary
- Revenue $16.4M (+47% YoY); net loss $7.3M vs $11.8M a year ago.
- Cash burn reduced to $2.2M in Q3, down from $4M in Q2 and $9.8M in Q1.
- Full-year revenue guidance raised to $62.5-$63.5M (prev $59-$61M); gross margin guided 71%-73%.
- FDA approved Tablet Remote Monitor; launched nSight platform. NAUTILUS trial enrollment on track for Q1 2024.
- First RNS implants in community setting under Project CARE; sufficient cash to fund operations into 2026.

## SEC filing metadata
- accession: 0001528287-23-000040
- form_type: 8-K
- ticker: NPCE
- cik: 0001528287
- company_name: NeuroPace Inc
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1528287/000152828723000040/0001528287-23-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1528287/000152828723000040/npce-20231106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001528287-23-000040
- JSON: https://secwatch.observer/filing/0001528287-23-000040.json
- Plain text: https://secwatch.observer/filing/0001528287-23-000040.txt

## Key facts
- Earnings Releases
  NeuroPace Inc reported third quarter ended September 30, 2023 results: revenue $16.4 million, net income $(7.3 million). Guidance raised.
  - Period: third quarter ended September 30, 2023
  - Revenue: $16.4 million
  - Net income: $(7.3 million)
  - Guidance: raised
  - Result: reported results
  source text: NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance Third quarter 2023 revenue of $16.4 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1528287/000152828723000040/0001528287-23-000040-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.